For the Inventor, By the Inventor

Enter assignee name

Shenzhen, China

Shenzhen Chipscreen Biosciences, Ltd.

USPTO Granted Patents = 9

CIPO Patents = 16

EPO Patents = 5

Trademarks = 1

Forward Citations = 41

Loading Chart...

Loading Chart...

50 inventors (with patents filed for the assignee):

Xian-Ping Lu (7 out of 8 patents)

Zhibin Li (6 out of 18 patents)

Song Shan (5 out of 7 patents)

4. Zhiqiang Ning (5 out of 6 patents)

5. Zhi-Bin Li (3 out of 3 patents)

6. Zhi-Qiang Ning (3 out of 3 patents)

7. Leming Shi (3 out of 4 patents)

8. Tuo Deng (3 out of 5 patents)

9. Xianping Lu (2 out of 9 patents)

10. Jindi Yu (2 out of 3 patents)

11. Aihua Xie (2 out of 2 patents)

12. Boyu Li (2 out of 2 patents)

13. Weiming Hu (2 out of 2 patents)

14. Qianjiao Yang (1 out of 3 patents)

15. Xianghui Wang (1 out of 8 patents)

9 patents: Sort by Forward Citations

1. 10011571 - Preparation method for aromatic heterocyclic compound used as selective JAK3 and/or JAK1 kinase inhibitor and application of aromatic heterocyclic compound (2018-07-03),

2. 9573901 - Crystal form of chidamide, preparation method and use thereof (2017-02-21),

3. 8211901 - Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors (2012-07-03),

4. 8178577 - Tricyclic derivatives as potent and selective histone deacetylase inhibitors (2012-05-15),

5. 8158656 - 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors (2012-04-17),

6. 7863315 - 2-indolinone derivatives as selective histone deacetylase inhibitors (2011-01-04),

7. 7550490 - Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity (2009-06-23),

8. 7268157 - Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity (2007-09-11),

9. 7244751 - Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity (2007-07-17),

Shenzhen Chipscreen Biosciences, Ltd. is a leading biopharmaceutical company focused on innovative drug discovery and development. With a strong emphasis on oncology and autoimmune diseases, Chipscreen Biosciences aims to provide effective and safe therapies for patients. The company's dedicated research and development teams work tirelessly to identify and develop novel small molecule drugs. Chipscreen Biosciences is committed to improving the quality of life for patients worldwide through scientific advancements and medical innovations.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

9 Patents

#410 in Shenzhen

#2,723 in China

Shenzhen, China

Shenzhen Chipscreen Biosciences, Ltd.

Forward Citations = 41

50 inventors:

Xian-Ping Lu (7 out of 8 patents)

Zhibin Li (6 out of 18 patents)

Song Shan (5 out of 7 patents)

4. Zhiqiang Ning (5 out of 6 patents)

5. Zhi-Bin Li (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…